24 November 2022
Philip Brown appointed chairman of Greenfern Industries
New Plymouth businessman Philip Brown has been appointed chairman of NZX-listed medicinal cannabis company Greenfern Industries Limited. The role was vacated ...
Read More
15 November 2022
Rua Opens 2022 He Ara Atawhai – Undergraduate and Postgraduate Scholarships
Rua is now inviting specific East Coast kura to nominate students for our undergraduate scholarships as well as inviting all postgraduate ...
Read More
15 November 2022
Eqalis receives GMP certification to accelerate local production of medicinal cannabis
Leading Bay of Plenty-based medicinal cannabis company Eqalis has successfully applied for and received its Good Manufacturing Practice (GMP) license, allowing ...
Read More
26 October 2022
Greenfern medicinal cannabis achieves stringent quality standards
Greenfern Industries is pleased to announce that recently received overseas lab testing results of their medicinal cannabis flower starting material has ...
Read More
19 October 2022
Rua Bioscience Confirms First International Order
Rua Bioscience Limited (NZX: RUA) formally announced today that it has received its first order via its German distributor Nimbus Health, ...
Read More
7 October 2022
Significant Headway Made with Trans-Tasman Medicinal Cannabis Partnership
Rua Bioscience’s cultivation partnership with Australian-based Cann Group is making significant headway; the two companies achieving key milestones this week. read ...
Read More
15 September 2022
New Zealand-grown cannabis-based medicine cuts cost for Kiwi patients
For the first time in New Zealand, Kiwi patients can now be prescribed New Zealand-grown, New Zealand-made cannabis medicine. Read more ...
Read More
15 September 2022
NZ’s first locally grown cannabis medicines get approval
“This is great news for many patients who have long sought legal access to both New Zealand-grown and made medicinal cannabis ...
Read More
9 September 2022
Greenfern Industries part of trio awarded grant to research new and innovative hemp-based food and cosmetic products
Greenfern Industries is part of a trio that has been awarded a further Bioresource Processing Alliance (BPA) grant to research high-value ...
Read More
29 August 2022
Greenfern eyes FDA-approved cannabinoid medicine opportunity as part of multi deal
Patients in New Zealand, Australia and the Pacific Islands could soon have access to Syndros, one of only four Food and ...
Read More
25 August 2022
Cannasouth Cultivation Facility Achieves GACP Certification
Cannasouth Limited (NZX:CBD) is pleased to announce that its subsidiary, Cannasouth Cultivation Limited, has today received it’s Good Agricultural and Collection ...
Read More
15 August 2022
Greenfern remains NZ’s only Toitū net carbonzero medicinal cannabis company, recertified again
Greenfern Industries continues to lead the way both locally and internationally, having been certified a Toitū net carbonzero organisation for the ...
Read More